Glocyp Syrup is a combination pharmaceutical formulation containing Cyproheptadine hydrochloride (2 mg), Tricholine Citrate (275 mg), and Sorbitol (3.575 g) per dose. Cyproheptadine is an antihistamine with antiserotonergic and anticholinergic properties, primarily used to alleviate allergic conditions such as rhinitis, urticaria, and angioedema by blocking histamine H1 receptors. It also stimulates appetite, making it beneficial in cases of anorexia and weight loss. Tricholine Citrate acts as a choleretic agent, promoting bile secretion and enhancing liver function, which supports digestion and metabolic processes. Sorbitol serves as a sweetening agent and mild laxative, improving palatability and gastrointestinal motility. Glocyp Syrup is indicated for the symptomatic treatment of allergic disorders, appetite stimulation in malnourished patients, and support of hepatic function. The syrup formulation ensures ease of administration, particularly in pediatric and geriatric populations. Dosage should be individualized based on patient age, weight, and clinical condition, with caution advised in patients with hepatic or renal impairment. Common adverse effects may include drowsiness, dry mouth, and gastrointestinal disturbances. Glocyp Syrup should be used under medical supervision, avoiding concomitant use with other central nervous system depressants.